{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:03:27Z","timestamp":1787069007917,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,25]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Since the onset of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic in 2019, considerable resources have been devoted to developing vaccines to reduce related deaths and the burden of disease. Various vaccine formulations eventually became available and were approved for clinical use. In this article, we have conducted a review of polymyalgia rheumatica (PMR) cases induced by different COVID-19 vaccines [Pfizer: BNT162b2, AstraZeneca: ChAdOx1-S, Moderna: mRNA-1273, and Janssen: Ad26.COV2.S)], as well as non-COVID-19 vaccines, such as influenza, zoster, hepatitis B, and tetanus vaccines. Additionally, this article investigates 3 cases with clinical presentations suggestive of PMR following COVID-19 mRNA vaccination. This study aims to offer valuable insights through sharing diagnostic and therapeutic experiences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>Three patients presented with severe pain and stiffness in both shoulder and pelvic girdle muscles, following COVID-19 mRNA vaccination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Clinical presentations, laboratory parameters, and echographic findings confirmed the diagnosis of PMR following COVID-19 mRNA vaccination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Patients received Prednisone and\/or Methotrexate adjusted to body weight.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Polymyalgia rheumatica resolved successfully without any adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>Although direct causality was not definitively established in this article, the BNT162b2 COVID-19 mRNA vaccine, similar to other vaccines, might be considered a potential trigger for PMR. This raises the need for further research into this issue and potentially other immunological outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000040204","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T11:01:37Z","timestamp":1730199697000},"page":"e40204","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Polymyalgia rheumatica following COVID-19 vaccination: Case series of 3 patients and literature review on polymyalgia rheumatica induced by various vaccines"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4734-843X","authenticated-orcid":false,"given":"Laure","family":"Irani","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, LAU Medical Center \u2013 Rizk Hospital, Zahar St., Achrafieh, Beirut, Lebanon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Bou Karroum","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, LAU Medical Center \u2013 Rizk Hospital, Zahar St., Achrafieh, Beirut, Lebanon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara","family":"Chehab","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, LAU Medical Center \u2013 Rizk Hospital, Zahar St., Achrafieh, Beirut, Lebanon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrine","family":"Abi Saad","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, LAU Medical Center \u2013 Rizk Hospital, Zahar St., Achrafieh, Beirut, Lebanon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Al Dailaty","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, LAU Medical Center \u2013 Rizk Hospital, Zahar St., Achrafieh, Beirut, Lebanon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roula","family":"Husni","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, LAU Medical Center \u2013 Rizk Hospital, Zahar St., Achrafieh, Beirut, Lebanon."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4081\/reumatismo.2018.1048","article-title":"Pathogenesis of polymyalgia rheumatica.","volume":"70","author":"Guggino","year":"2018","journal-title":"Reumatismo"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"117","DOI":"10.14740\/jmc2788w","article-title":"Polymyalgia rheumatica after influenza vaccine.","volume":"8","author":"Salehi","year":"2017","journal-title":"J Med Case"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"76","DOI":"10.5114\/reum.2020.95360","article-title":"Polymyalgia rheumatica following infective triggers or vaccinations: a different subset of disease?","volume":"58","author":"Falsetti","year":"2020","journal-title":"Reumatologia"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/art.34356","article-title":"2012 Provisional classification criteria for polymyalgia rheumatica: a European league against rheumatism\/American College of Rheumatology collaborative initiative.","volume":"64","author":"Dasgupta","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/agm2.12171","article-title":"Polymyalgia rheumatica as uncommon adverse event following immunization with COVID-19 vaccine: a case report and review of literature.","volume":"4","author":"Manzo","year":"2021","journal-title":"Aging Med (Milton)"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2169\/internalmedicine.8651-21","article-title":"New-onset polymyalgia rheumatica following the administration of the Pfizer-BioNTech COVID-19 vaccine.","volume":"61","author":"Osada","year":"2022","journal-title":"Intern Med"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2147\/IJGM.S92435","article-title":"A case of polymyalgia rheumatica following influenza B infection.","volume":"8","author":"Iwata","year":"2015","journal-title":"Int J Gen Med"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/0961203311430222","article-title":"Giant cell arteritis and polymyalgia rheumatica after influenza vaccination: report of 10 cases and review of the literature.","volume":"21","author":"Soriano","year":"2012","journal-title":"Lupus"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5152\/eurjrheum.2019.19152","article-title":"Relapse of polymyalgia rheumatica following adjuvanted influenza vaccine: a case-based review.","volume":"7","author":"Bassendine","year":"2019","journal-title":"Eur J Rheumatol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0248-8663(00)00307-6","article-title":"Vascularites postvaccinales: \u00e0 propos de trois observations [Postvaccine vasculitis: a report of three cases].","volume":"22","author":"Saadoun","year":"2001","journal-title":"Rev Med Interne"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/jgs.2000.48.11.1533a","article-title":"Polymyalgia rheumatica following influenza vaccination.","volume":"48","author":"Liozon","year":"2000","journal-title":"J Am Geriatr Soc"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"102732","DOI":"10.1016\/j.autrev.2020.102732","article-title":"Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: a study of 12 patients and a literature review.","volume":"20","author":"Liozon","year":"2021","journal-title":"Autoimmun Rev"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/rheumatology\/38.10.978","article-title":"Rheumatic disorders developed after hepatitis B vaccination.","volume":"38","author":"Maillefert","year":"1999","journal-title":"Rheumatology"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jns.2017.01.053","article-title":"Giant cell arteritis following varicella zoster vaccination.","volume":"375","author":"Lotan","year":"2017","journal-title":"J Neurol Sci"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"ofaa647","DOI":"10.1093\/ofid\/ofaa647","article-title":"Increased incidence of giant cell arteritis after introduction of a live varicella zoster virus vaccine.","volume":"8","author":"Agger","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"2334084","DOI":"10.1080\/21645515.2024.2334084","article-title":"Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: results from a nationwide survey.","volume":"20","author":"Jarrot","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"105334","DOI":"10.1016\/j.jbspin.2021.105334","article-title":"Polymyalgia rheumatica following COVID-19 vaccination: a case-series of ten patients.","volume":"89","author":"Ottaviani","year":"2022","journal-title":"Joint Bone Spine"},{"key":"R18-20250504","first-page":"e37782","article-title":"Rare cases of polymyalgia rheumatica after receiving COVID-19 vaccinations.","volume":"15","author":"Furr","year":"2023","journal-title":"Cureus"},{"key":"R19-20250504","first-page":"1","article-title":"Clinical vignette. To vaccinate or not to vaccinate: PMR relapse after COVID booster vaccination.","volume":"27","author":"Dattoma","year":"2023","journal-title":"Proc UCLA Health"},{"key":"R20-20250504","first-page":"e25388","article-title":"A case of giant cell arteritis with a normal erythrocyte sedimentation rate (ESR) post ChAdOx1 nCoV-19 vaccination.","volume":"14","author":"Xia","year":"2022","journal-title":"Cureus"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3390\/vaccines11020434","article-title":"New onset of giant cell arteritis following ChAdOx1-S (Vaxevria\u00ae) vaccine administration.","volume":"11","author":"Lo Sardo","year":"2023","journal-title":"Vaccines"},{"issue":"Suppl 1","key":"R22-20250504","doi-asserted-by":"crossref","first-page":"keac133.060","DOI":"10.1093\/rheumatology\/keac133.060","article-title":"P061 polymyalgia rheumatica following COVID-19 vaccination: presentation of four patients.","volume":"61","author":"Mohareb","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/1756-185X.14084","article-title":"Identification of serum interleukin-13 and interleukin-13 receptor subunit expressions: rheumatoid arthritis-associated interstitial lung disease.","volume":"24","author":"Hussein","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s10067-021-06041-7","article-title":"New-onset giant cell arteritis following COVID-19 mRNA (BioNTech\/Pfizer) vaccine: a double-edged sword?","volume":"41","author":"Anzola","year":"2022","journal-title":"Clin Rheumatol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"105282","DOI":"10.1016\/j.jbspin.2021.105282","article-title":"SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: \u201cCan SARS-CoV-2 trigger relapse of polymyalgia rheumatica?\u201d by Manzo et al. Joint Bone Spine 2021;88:105150.","volume":"89","author":"Cadiou","year":"2022","journal-title":"Joint Bone Spine"},{"key":"R26-20250504","first-page":"e26617","article-title":"An unusual side effect of the COVID-19 vaccine: a possible trigger of polymyalgia rheumatica.","volume":"14","author":"Ahmad","year":"2022","journal-title":"Cureus"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"2050313X241235830","DOI":"10.1177\/2050313X241235830","article-title":"Case report of transient polymyalgia rheumatica after receiving the first dose of the BNT162b2 mRNA COVID-19 vaccine.","volume":"12","author":"Matsuzono","year":"2024","journal-title":"SAGE Open Med Case Rep"},{"key":"R28-20250504","first-page":"e43","article-title":"Polymyalgia rheumatica and giant cell arteritis with intracranial involvement postvaccination anti-COVID-19.","volume":"159","author":"Arias","year":"2022","journal-title":"Med Clin (Engl Ed)"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2169\/internalmedicine.8829-21","article-title":"Self-limited polymyalgia rheumatica-like syndrome following mRNA-1273 SARS-CoV-2 vaccination.","volume":"61","author":"Izuka","year":"2022","journal-title":"Intern Med"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2174\/1573397118666220211155716","article-title":"Rheumatologic manifestations of post SARS-CoV-2 infection: a case series.","volume":"18","author":"Metyas","year":"2022","journal-title":"Curr Rheumatol Rev"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/03009742.2022.2070959","article-title":"Self-limiting reactive disease mimicking polymyalgia rheumatica following Moderna COVID-19 vaccine.","volume":"51","author":"Nielsen","year":"2022","journal-title":"Scand J Rheumatol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.2169\/internalmedicine.0319-22","article-title":"A case of sequential development of polymyalgia rheumatica and guillain-barr\u00e9 syndrome following administration of the Pfizer-BioNTech COVID-19 vaccine.","volume":"61","author":"Yamada","year":"2022","journal-title":"Intern Med"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/rheumatology\/keab756","article-title":"Risk of giant cell arteritis and polymyalgia rheumatica following COVID-19 vaccination: a global pharmacovigilance study.","volume":"61","author":"Mettler","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.2169\/internalmedicine.8934-21","article-title":"Polymyalgia rheumatica following COVID-19 vaccination.","volume":"61","author":"Yokote","year":"2022","journal-title":"Intern Med"},{"key":"R35-20250504","article-title":"Two billion doses of Astra Zeneca\u2019s COVID-19 vaccine supplied to countries across the world less than 12 months after first approval.","year":"2021"},{"key":"R36-20250504","article-title":"U.S. government purchases additional 100 million doses of Moderna\u2019s COVID-19 vaccine."},{"key":"R37-20250504","first-page":"162","article-title":"Myofasciite \u00e0 macrophages et hydroxyde d\u2019aluminium: vers la d\u00e9finition d\u2019un syndrome des adjuvants [Lessons from macrophagic myofasciitis: towards definition of a vaccine adjuvant-related syndrome].","volume":"159","author":"Gherardi","year":"2003","journal-title":"Rev Neurol (Paris)"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/(SICI)1097-4598(200005)23:5<824::AID-MUS24>3.0.CO;2-M","article-title":"Polymyalgia rheumatica following influenza vaccination.","volume":"23","author":"Perez","year":"2000","journal-title":"Muscle Nerve"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040204","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T20:53:28Z","timestamp":1746305608000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":38,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040204","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,25]]}}}